ResearcherEugene Applebaum College of Pharmacy and Health SciencesActive in the last 2 years
Prashant Kesharwani
Matched on ORCID iD 0000-0002-0890-769X; OpenAlex author ID A5045032651. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2015: 3 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 7
- Programmable Poly-Lactic-Co-Glycolic Acid Nanocarriers for Precision Therapy of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1002/ddr.70307↗
- Gemcitabine-loaded nanoparticles for pancreatic cancer: from mechanistic innovations to clinical translation. Last author DOI 10.1016/j.ijpharm.2026.126904↗
- Exosome-mediated communication in pancreatic cancer: From molecular crosstalk to clinical translation. Last author DOI 10.1016/j.ijbiomac.2025.145766↗
- Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Last author DOI 10.1186/s12943-022-01696-5↗
- Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. Co-author DOI 10.1016/j.colsurfb.2015.05.007↗
- Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Co-author DOI 10.1016/j.colsurfb.2015.09.043↗
- Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.biomac.5b00941↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shruti Gupta · 1 shared paper, 2026 · strength 0.36
- Sonam Chosdon · 1 shared paper, 2026 · strength 0.32
- Mohammad Sameer Khan · 1 shared paper, 2025 · strength 0.30
- Sanjeev Banerjee · 3 shared papers, 2015 · strength 0.19
- Paper Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. DOI 10.1016/j.colsurfb.2015.05.007↗
- Paper Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem… DOI 10.1021/acs.biomac.5b00941↗
- Paper Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 … DOI 10.1016/j.colsurfb.2015.09.043↗
- Subhash Padhyé · 3 shared papers, 2015 · strength 0.19
- Paper Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. DOI 10.1016/j.colsurfb.2015.05.007↗
- Paper Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem… DOI 10.1021/acs.biomac.5b00941↗
- Paper Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 … DOI 10.1016/j.colsurfb.2015.09.043↗
- Arun K. Iyer · 3 shared papers, 2015 · strength 0.19
- Paper Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. DOI 10.1016/j.colsurfb.2015.05.007↗
- Paper Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem… DOI 10.1021/acs.biomac.5b00941↗
- Paper Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 … DOI 10.1016/j.colsurfb.2015.09.043↗
- Fazlul H. Sarkar · 3 shared papers, 2015 · strength 0.19
- Paper Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. DOI 10.1016/j.colsurfb.2015.05.007↗
- Paper Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem… DOI 10.1021/acs.biomac.5b00941↗
- Paper Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 … DOI 10.1016/j.colsurfb.2015.09.043↗
- Zhe Liu · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.